ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Regístrate

¿Ya eres miembro? Iniciar sesión

Los Principales Corredores en Línea

Más Corredores en Línea

Datos
Noticias
Herramientas
Mercados
Descubrir

Hot Features

Follow Feed

Conéctese con traders e inversores en nuestra comunidad Follow Feed.

Flujo de Opciones

Explora datos de opciones completos y utiliza filtros avanzados con Options Flow.

Monitor

Organiza y monitorea tu lista de seguimiento de acciones y activos con Monitor.
Iniciar Sesión Premium IconPremium Help Menu
S&P 500
5,970.84
-1.11%
Dow Jones
42,992.21
-0.77%
US Dollar vs MXN
20.3272
0.00%
Brent Oil
73.44
0.00%
Bitcoin
94,271.24
0.12%
Pepperstone
Advertisement
Registration Strip Icon for default Regístrate gratis para obtener cotizaciones en tiempo real, gráficos interactivos, flujo de opciones en vivo y más.
Regístrate
  1. Inicio
  2. Invertir
  3. Acciones
  4. Alemania
  5. TG

  6. Bristol Myers Squibb (BRM) Cotización

Bristol Myers Squibb

Bristol Myers Squibb (BRM)

Biorem Inc
55.35
0.02
(0.04%)
Cerrado 28 Diciembre 3:00PM
Realtime Data

Herramientas de nivel profesional para inversores individuales.

Premium

Estadísticas y detalles clave

Último Precio
55.35
Postura de Compra
55.15
Postura de Venta
55.54
Volume Operado de la Acción
3,699
55.20 Rango del Día 55.99
36.315 Rango de 52 semanas 58.32
Capitalización de Mercado [m]
112.26B
Precio Anterior
55.33
Precio de Apertura
55.52
Hora
68
@
55.21
Última hora de negociación
Volumen financiero
-
Precio Promedio Ponderado
-
Volumen promedio (3 m)
7,297
Acciones en circulación
2,028,176,674
Rendimiento del Dividendo
4.67%
Ratio Precio/Utilidad
14.58
Beneficio por acción (BPA)
3.96
turnover
45.01B
Beneficio neto
8.03B

Acerca de Bristol Myers Squibb

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
www.bms.com
Sede
Wilmington, Delaware, USA
Fundado
-
Bristol Myers Squibb is listed in the Pharmaceutical Preparations sector of the Tradegate (DE) with ticker BRM. The last closing price for Bristol Myers Squibb was 55.33 €. Over the last year, Bristol Myers Squibb shares have traded in a share price range of 36.315 € to 58.32 €.

Bristol Myers Squibb currently has 2,028,176,674 shares in issue. The market capitalisation of Bristol Myers Squibb is 112.22 € billion. Bristol Myers Squibb has a price to earnings ratio (PE ratio) of 14.58.

BRM Últimas noticias

Más noticias
No news to show yet.
Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
11.332.4620510921954.0255.9953.2545255.00302669DE
4-0.33-0.59267241379355.6857.2952.36554954.84749327DE
126.35512.970711297148.99558.3247.18729752.68907151DE
2615.57539.157762413639.77558.3236.315872046.29527141DE
528.1517.266949152547.258.3236.3151047844.42639659DE
1560.330.59978189749255.0280.536.315494048.51918336DE
260-1.76-3.0817720189157.1180.536.315446050.12070323DE

BRM - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de Bristol Myers Squibb?
El precio actual de las acciones de Bristol Myers Squibb es 55.35 €
¿Cuántas acciones de Bristol Myers Squibb están en circulación?
Bristol Myers Squibb tiene 2,028,176,674 acciones en circulación
¿Cuál es la capitalización de mercado de Bristol Myers Squibb?
La capitalización de mercado de Bristol Myers Squibb es EUR 112.22B
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de Bristol Myers Squibb?
Bristol Myers Squibb ha negociado en un rango de 36.315 € a 58.32 € durante el último año
¿Cuál es el ratio PE (precio/beneficio) de Bristol Myers Squibb?
El ratio precio/beneficio de Bristol Myers Squibb es 14.58
¿Cuál es el ratio de efectivo a ventas de Bristol Myers Squibb?
El ratio de efectivo a ventas de Bristol Myers Squibb es 2.6
¿Cuál es la moneda de reporte de Bristol Myers Squibb?
Bristol Myers Squibb presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de Bristol Myers Squibb?
El último ingresos anual de Bristol Myers Squibb es USD 45.01B
¿Cuál es el último beneficio anual de Bristol Myers Squibb?
El último beneficio anual de Bristol Myers Squibb es USD 8.03B
¿Cuál es la dirección registrada de Bristol Myers Squibb?
La dirección registrada de Bristol Myers Squibb es 1209 ORANGE STREET, NEW CASTLE, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de Bristol Myers Squibb?
La dirección del sitio web de Bristol Myers Squibb es www.bms.com
¿En qué sector industrial opera Bristol Myers Squibb?
Bristol Myers Squibb opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
Z4UreAlpha Tech Corp
2.60 €
(114.70%)
8.05k
510Graphex Group Limited
0.392 €
(106.32%)
16.46k
34Q0Quantum eMotion Inc
0.73 €
(103.91%)
2.99M
M000Vertical Aerospace Ltd
14.50 €
(101.39%)
8.16k
2WOWide Open Agriculture Ltd
0.01 €
(100.00%)
18k
ANLAnalog Devices Inc
9.6728 €
(-95.32%)
1.25k
E3O1Nexoptic Technology Corp
0.007 €
(-62.16%)
12.62k
WWTWater Ways Technologies Inc
0.003 €
(-50.00%)
181.5k
1RR1Rokmaster Resources Corp
0.006 €
(-50.00%)
19k
7CCCheckCap Ltd
1.14 €
(-47.22%)
265
PF8European Lithium Limited
0.024 €
(18.81%)
14.01M
D7GNel ASA
0.2429 €
(-3.07%)
5.39M
RQ0DWave Quantum Inc
9.474 €
(21.03%)
3.1M
34Q0Quantum eMotion Inc
0.73 €
(103.91%)
2.99M
M11First Graphene Limited
0.019 €
(4.40%)
2.5M

Discusión

Ver feed completo
JustJack JustJack 3 minutos hace
Not much, if anything, to laugh about with this share selling scheme. 

Unless you are Steve or Alexoops I guess.  
AITX
YY1000 YY1000 5 minutos hace
There are two reasons cited for why the '953 patent cannot claim priority date from the '048 provisional: (1) the change from C2 to C1 (which ENTA argued was correcting a typographical error) and (2) "the disclosure of a broad genus in the ‘048 Provisional fails to provide written description suppor
ENTA PFE
sharkey1 sharkey1 5 minutos hace
BS rack 186, but I am glad to see you spending a lot of useless vile energy trashing people on this board,
takes a lot of time to come up the stuff you post.
ELTP
ddls ddls 5 minutos hace
Buy: 0 - Neutral: 129,911 - Sell: 13,816,260 😭

Friday 12/27/24
BIEL
yman yman 6 minutos hace
Hey Mungo did you try contacting the Ant man? If he thinks he has a real chance with his case, he may be interested in more shares. How many shares are you talking about, I might be interested.
NNLX
Implanting Implanting 6 minutos hace
O.K. what's being discussed in the interview IMO will be the MAJOR catalyst for a much higher gold price in the next few years. It's geopolitical in nature and it's most likely going to involve the U.S. and China in a military conflict of some sort.

The fellow in the interview is ver
FFMGF
Filterthenoise Filterthenoise 7 minutos hace
Im a shareholder
RNVA
RKMKE RKMKE 7 minutos hace
Pumpers are getting out control with their rotten theories... so tell us whats has been accomplished and what cam to fruition???


WDLF
dstock07734 dstock07734 9 minutos hace
Mike,

Enlighten me why the unpublished paper seems like having conclusion different from the one published on Nature five years ago.

The published paper states that neoadjuvant therapy can double OS in comparison of adjuvant treatment while the unpublished paper claims
NWBO
nyt nyt 10 minutos hace
All the news the emu promised to start presenting........ ITS TOO MUCH! STOP! I CAN'T TAKE IT ALL.....HALP! AAAaaaargh
VPLM
sokol sokol 10 minutos hace
The J.P. Morgan Healthcare Conference is widely regarded as the premier event in the healthcare industry. It is the largest and most influential healthcare investment symposium, attracting top executives, investors, and innovators from over 400 organizations globally. Known for shaping industry tren
AVXL
al44 al44 11 minutos hace
An easier way to show illegals the door

By Philip Lillingston

A recent article in the Wall Street Journal by a Jess Bravin reported that attorneys general of many blue states are not going to give up quietly when Donald Trump, as president, begins to honor his election
Vexari Vexari 12 minutos hace
Gaining strength

Against the cartels grip

Tide is turning

Retribution

Is near
PFE
glenn1919 glenn1919 13 minutos hace
cocp............................https://stockcharts.com/h-sc/ui?s=cocp&p=D&yr=0&mn=2&dy=12&id=p84071410134
meixatech meixatech 13 minutos hace
Pharmacological modulation of hypoxia-induced respiratory neuroplasticity

Sara Turner , Kristi Streeter , John Greer, Gordon S Mitchell, David D Fuller

PMCID: PMC6155458 NIHMSID: NIHMS987117 PMID: 29197629
Respir Physiol Neurobiol. 2017 Nov 29;256:4–14. doi: 10
RSPI
CaptainObvious CaptainObvious 13 minutos hace
I'll keep mine at .57 since we are talking the first full day after approval, and no other announcements.
NWBO
BullNBear52 BullNBear52 14 minutos hace
Mets have big Alonso decision on their hands
December 27th, 2024
Anthony DiComo

https://www.mlb.com/news/mets-biggest-question-before-2025-spring-training

By now Alonso has to be feeling unloved after the Mets signed Soto and they still haven't made a dece
glenn1919 glenn1919 15 minutos hace
cocp...........................................https://stockcharts.com/h-sc/ui?s=cocp&p=W&b=5&g=0&id=p86431144783
COCP
Genz2 Genz2 15 minutos hace
https://www.cnbc.com/amp/2024/12/28/why-microsoft-amazon-google-and-meta-are-betting-on-nuclear-power.html

Now why aren’t these companies betting on the unlimited supply of solar and mega packs with Elon!! Are we going to have another nuclear meltdown and destroy the environment?? E
gawti88 gawti88 16 minutos hace
lol bro, insane how big this company has grown. lol.... 60k+ days now haha man i remember they were doing 60k sales in a month LOL.

60k months are now 60k days. This is probably a top 5 otc pick. Get ready.
CEOS
al44 al44 17 minutos hace
Your neighbor is deep in debt

By Kevin Finn

What would you say about a family of four who earns $44,000 per year and spends $61,000? Crazy, right? It gets worse. The family is $362,000 in debt, and that debt alone is generating $10,000 a year in interest.
Clark6290 Clark6290 18 minutos hace
His name is Judge Lamberth. I fail to understand why all the derogatory names for him, think the emoji 🤔 fella started it
FNMA
flipper44 flipper44 18 minutos hace
Again, FeMike’s survey question is asked under the synthetic given that nothing else will be announced when (likely) approval is announced.

I agree with FeMike’s point that approval should not be announced in isolation.
NWBO has one temporary advantage right now. It held bac
NWBO
Dorick Dorick 18 minutos hace
Sorry to hear that, Mr. PC. Get well soon!
FLCX

Su Consulta Reciente

TG
BRM
Bristol Myers Squibb
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

México
Empresa
Negocios
Popular
Obtener la aplicación
App Store
Google Play

Soporte: (55) 4170 8128 | soporte@advfn.mx

Al acceder a los servicios disponibles de ADVFN usted acepta quedar sujerto a los Términos y Condiciones

© 2024 ADVFN PLC - Todos los derechos reservados